Pilot Study for Patient-cooperative Control Strategies for Actuated Transfemoral Prostheses
NCT ID: NCT02310841
Last Updated: 2015-04-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
1 participants
INTERVENTIONAL
2013-03-31
2015-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficiency of Hydraulic Microprocessor Prosthetic Foot for Traumatic Transtibial Amputees
NCT02383446
Effectiveness of Frontal Plane Adaptability in a Novel Foot Prosthesis
NCT06214026
Comparison Between Implanted Functional Electrical Stimulation and Foot Orthosis
NCT01415700
Sensor Controlled Compliance Evaluation of Compressive Elastic Stockings
NCT02792907
Characterizing Ankle Function During Sloped Locomotion for Prosthesis Development
NCT01784003
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Hypothesis: Subjects can use our transfemoral prosthesis to walk on level-ground, to climb several steps and to overcome small obstacles without prior training. The user-cooperative control is intuitive and easily learnable.
Objective of the study: This pilot study is meant to investigate the general feasibility of novel control strategies for actuated transfemoral prostheses. Parameters of a standard gait analysis, like ground reaction forces and kinematics (using a motion capture system), will be recorded. From this data, gait symmetry, step length, walking speed, and other measures can be calculated. The subjective impression of the user will be evaluated with a questionnaire.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
unilateral transfemoral amputees
ANGELAA
Different control strategies with transfemoral prosthesis prototype ANGELAA, developed at the Sensory-Motor Systems Lab, ETH Zurich, not commercially available, only 1 device exists
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ANGELAA
Different control strategies with transfemoral prosthesis prototype ANGELAA, developed at the Sensory-Motor Systems Lab, ETH Zurich, not commercially available, only 1 device exists
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Written consent of participant
* For amputees: regular use of a transfemoral prosthesis
* For amputees: transfemoral amputation
Exclusion Criteria
* For amputees: mobility class 1
* For amputees: no stable residual leg volume
* For amputees: constrictive contractures
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Balgrist University Hospital
OTHER
Swiss Federal Institute of Technology
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Verena Klamroth
MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Robert Riener, Prof. Dr
Role: PRINCIPAL_INVESTIGATOR
Sensory Motor Systems Lab, ETH Zurich
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Balgrist
Zurich, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2013-MD-0004
Identifier Type: OTHER
Identifier Source: secondary_id
KEK-ZH-2013-0034
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.